Biopin
Biotech Foundry · by Bversity

Digital biology for people already working in life science

Applied programmes for professionals at GCCs, CROs and life-science IT firms. The first, the Digital Biology track, is open now.

Digital Biology trackLive now
FellowshipComing soon
Biotech 30 Under 302027
Now inviting · Digital Biology track30 Nov – 6 Dec 2026 · Bengaluru and Hyderabad. Request an invite.
Programmes

What’s running and what’s next

Live now

Digital Biology track GCC edition

Seven days to build an AI tool for life-science work: four online evenings, then three days in the city, ending with a demo night.

  • 30 Nov – 6 Dec 2026
  • Bengaluru and Hyderabad
  • 15 seats per city
  • For professionals at GCCs, CROs and life-science IT firms
Request an invite
Coming soon

Biotech Foundry Fellowship

A selective programme for people building a career across AI and biology.

Coming soon

For Industry

Programmes built for pharma and biotech teams.

2027

Biotech 30 Under 30

Recognising 30 people under 30 doing real work in digital biology.

Why the Foundry

Pharma, biotech and the teams that serve them are bringing AI into how they work with biological data. People who can work across biology and data are hard to find. The Foundry trains people already in the industry to do that work.

The people behind the Foundry

Founded by scientists. Built for industry

Sudharsan V
Co-founder & CEO

Sudharsan V

PhD in developmental biology, Germany. Published at EMBL. Science communicator on 100+ stages.

Raghul J
Co-founder · Academics

Raghul J

Chief Academic Officer.

Saiganesh V
Co-founder · Enterprise

Saiganesh V

Director of Finance and Corporate Relations. Leads enterprise partnerships.

Godwin Immanuel
Co-founder · Admissions

Godwin Immanuel

Director of Admissions.

Backers & mentors
  • Nagaraja PrakasamInvestor, global mentor
  • Suresh SambandamCEO, Kissflow
  • Lalith KishoreCOO, C-CAMP
  • Ratish KrishnanMentor
Built on Bversity

Since 2021, Bversity’s industry-immersive programs have placed graduates at IQVIA, Syneos Health, Parexel and Novartis GCC.